Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide

BACKGROUND: Phosphate binders are widely used to achieve serum phosphorus control in patients with end-stage renal disease. However, the large pill burden associated with these medications may decrease adherence to therapy. In clinical trials, sucroferric oxyhydroxide (SO) demonstrated equivalent co...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Kathryn, Ficociello, Linda H, Hunt, Abigail E, Mullon, Claudy, Brunelli, Steven M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348967/
https://www.ncbi.nlm.nih.gov/pubmed/30774412
http://dx.doi.org/10.2147/IJNRD.S182747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348967/
https://www.ncbi.nlm.nih.gov/pubmed/30774412
http://dx.doi.org/10.2147/IJNRD.S182747

Ejemplares similares